1116 related articles for article (PubMed ID: 16928541)
21. The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma.
Rizk NP; Bach PB; Schrag D; Bains MS; Turnbull AD; Karpeh M; Brennan MF; Rusch VW
J Am Coll Surg; 2004 Jan; 198(1):42-50. PubMed ID: 14698310
[TBL] [Abstract][Full Text] [Related]
22. Local recurrence after total or subtotal esophagectomy for esophageal cancer.
Blewett CJ; Miller JD; Ramlawi B; Young JE; BennettWF ; Urschel JD
J Exp Clin Cancer Res; 2001 Mar; 20(1):17-9. PubMed ID: 11370823
[TBL] [Abstract][Full Text] [Related]
23. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial.
Omloo JM; Lagarde SM; Hulscher JB; Reitsma JB; Fockens P; van Dekken H; Ten Kate FJ; Obertop H; Tilanus HW; van Lanschot JJ
Ann Surg; 2007 Dec; 246(6):992-1000; discussion 1000-1. PubMed ID: 18043101
[TBL] [Abstract][Full Text] [Related]
24. Surgical treatment for carcinoma of the esophagus in the elderly patient.
Xijiang Z; Xizeng Z; Xishan H; Hongjing J
Ann Thorac Cardiovasc Surg; 1999 Jun; 5(3):182-6. PubMed ID: 10413765
[TBL] [Abstract][Full Text] [Related]
25. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.
Altorki NK; Lee PC; Liss Y; Meherally D; Korst RJ; Christos P; Mazumdar M; Port JL
Ann Surg; 2008 Mar; 247(3):434-9. PubMed ID: 18376186
[TBL] [Abstract][Full Text] [Related]
26. [Changes and complication rate in surgery for thoracic esophageal carcinoma].
Meyer T; Merkel S; Göhl J; Stumpf P; Hohenberger W
Zentralbl Chir; 2003 Aug; 128(8):631-9. PubMed ID: 12931257
[TBL] [Abstract][Full Text] [Related]
27. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.
Tachibana M; Kinugasa S; Yoshimura H; Shibakita M; Tonomoto Y; Dhar DK; Nagasue N
Am J Surg; 2005 Jan; 189(1):98-109. PubMed ID: 15701501
[TBL] [Abstract][Full Text] [Related]
28. Have surgical outcomes of pathologic T4 esophageal squamous cell carcinoma really improved? Analysis of 268 cases during 45 years of experience.
Shimada H; Shiratori T; Okazumi S; Matsubara H; Nabeya Y; Shuto K; Akutsu Y; Hayashi H; Isono K; Ochiai T
J Am Coll Surg; 2008 Jan; 206(1):48-56. PubMed ID: 18155568
[TBL] [Abstract][Full Text] [Related]
29. [Surgical therapy for esophageal carcinoma: a prospective 20-year analysis].
Gockel I; Sultanov FS; Domeyer M; Trinh TT; Gönner U; Junginger T
Zentralbl Chir; 2008 Jun; 133(3):260-6. PubMed ID: 18563693
[TBL] [Abstract][Full Text] [Related]
30. A comparison of outcome after resection for squamous cell carcinomas and adenocarcinomas of the esophagus and cardia.
Law SY; Fok M; Cheng SW; Wong J
Surg Gynecol Obstet; 1992 Aug; 175(2):107-12. PubMed ID: 1636132
[TBL] [Abstract][Full Text] [Related]
31. Transhiatal versus transthoracic esophagectomy for clinical stage I esophageal carcinoma.
Berdejo L
Hepatogastroenterology; 1995; 42(6):789-91. PubMed ID: 8847024
[TBL] [Abstract][Full Text] [Related]
32. [Differentiated surgical therapy of esophageal carcinoma].
Junginger T; Dutkowski P; Böttger T; Wahl W
Chirurg; 1995 Jul; 66(7):693-703. PubMed ID: 7545571
[TBL] [Abstract][Full Text] [Related]
33. Relationships between operative approaches and outcomes in esophageal cancer.
Pommier RF; Vetto JT; Ferris BL; Wilmarth TJ
Am J Surg; 1998 May; 175(5):422-5. PubMed ID: 9600292
[TBL] [Abstract][Full Text] [Related]
34. Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease.
Stiles BM; Mirza F; Coppolino A; Port JL; Lee PC; Paul S; Altorki NK
Ann Thorac Surg; 2011 Aug; 92(2):491-6; discussion 496-8. PubMed ID: 21704291
[TBL] [Abstract][Full Text] [Related]
35. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
[TBL] [Abstract][Full Text] [Related]
36. Pathologic prognostic factors in esophageal squamous cell carcinoma: a follow-up study of 74 patients with or without preoperative chemoradiation therapy.
Torres CM; Wang HH; Turner JR; Richards W; Sugarbaker D; Shahsafaei A; Odze RD
Mod Pathol; 1999 Oct; 12(10):961-8. PubMed ID: 10530561
[TBL] [Abstract][Full Text] [Related]
37. [The patterns and prognostic factors of abdominal lymph node metastasis in patients with the middle thoracic esophageal squamous cell carcinoma].
Wang Z; Liu XY; Liu FY
Zhonghua Wai Ke Za Zhi; 2008 Dec; 46(23):1800-3. PubMed ID: 19094790
[TBL] [Abstract][Full Text] [Related]
38. Lymph node dissection for thoracic esophageal carcinoma. Two- and 3-field lymph node dissection.
Kato H
Ann Chir Gynaecol; 1995; 84(2):193-9. PubMed ID: 7574380
[TBL] [Abstract][Full Text] [Related]
39. Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results study.
Schwer AL; Ballonoff A; McCammon R; Rusthoven K; D'Agostino RB; Schefter TE
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):449-55. PubMed ID: 18538500
[TBL] [Abstract][Full Text] [Related]
40. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
